BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18606313)

  • 21. Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-Q(92), responsible for human hypertrophic cardiomyopathy.
    Lim DS; Oberst L; McCluggage M; Youker K; Lacy J; DeMayo F; Entman ML; Roberts R; Michael LH; Marian AJ
    J Mol Cell Cardiol; 2000 Mar; 32(3):365-74. PubMed ID: 10731436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of magnetic resonance imaging in vivo for the assessment of the progression of systolic and diastolic dysfunction in a mouse model of dilated cardiomyopathy.
    Drelicharz Ł; Woźniak M; Skórka T; Tyrankiewicz U; Heinze-Paluchowska S; Jabłońska M; Gebska A; Chłopicki S
    Kardiol Pol; 2009 Apr; 67(4):386-95. PubMed ID: 19492251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted disruption of the cardiac troponin T gene causes sarcomere disassembly and defects in heartbeat within the early mouse embryo.
    Nishii K; Morimoto S; Minakami R; Miyano Y; Hashizume K; Ohta M; Zhan DY; Lu QW; Shibata Y
    Dev Biol; 2008 Oct; 322(1):65-73. PubMed ID: 18671960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dilated cardiomyopathy in transgenic mice expressing HIV Tat.
    Fang Q; Kan H; Lewis W; Chen F; Sharma P; Finkel MS
    Cardiovasc Toxicol; 2009 Mar; 9(1):39-45. PubMed ID: 19337863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
    Blyszczuk P; Kania G; Dieterle T; Marty RR; Valaperti A; Berthonneche C; Pedrazzini T; Berger CT; Dirnhofer S; Matter CM; Penninger JM; Lüscher TF; Eriksson U
    Circ Res; 2009 Oct; 105(9):912-20. PubMed ID: 19762681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of mitochondrial dysfunction by EPR technique in mouse model of dilated cardiomyopathy.
    Elas M; Bielanska J; Pustelny K; Plonka PM; Drelicharz L; Skorka T; Tyrankiewicz U; Wozniak M; Heinze-Paluchowska S; Walski M; Wojnar L; Fortin D; Ventura-Clapier R; Chlopicki S
    Free Radic Biol Med; 2008 Aug; 45(3):321-8. PubMed ID: 18466775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
    Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
    Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene-Targeted Mice with the Human Troponin T R141W Mutation Develop Dilated Cardiomyopathy with Calcium Desensitization.
    Ramratnam M; Salama G; Sharma RK; Wang DW; Smith SH; Banerjee SK; Huang XN; Gifford LM; Pruce ML; Gabris BE; Saba S; Shroff SG; Ahmad F
    PLoS One; 2016; 11(12):e0167681. PubMed ID: 27936050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-dimensional MR microscopy of a transgenic mouse model of dilated cardiomyopathy.
    Sze RW; Chan CB; Dardzinski BJ; Dunn S; Sanbe A; Schmithorst V; Robbins J; Holland SK; Strife JL
    Pediatr Radiol; 2001 Feb; 31(2):55-61. PubMed ID: 11214686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation.
    Marian AJ; Senthil V; Chen SN; Lombardi R
    J Am Coll Cardiol; 2006 Feb; 47(4):827-34. PubMed ID: 16487852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
    Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-lipoic acid prevents lipotoxic cardiomyopathy in acyl CoA-synthase transgenic mice.
    Lee Y; Naseem RH; Park BH; Garry DJ; Richardson JA; Schaffer JE; Unger RH
    Biochem Biophys Res Commun; 2006 May; 344(1):446-52. PubMed ID: 16603124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role of N-cadherin in hepatocyte growth factor (HGF) mediated improvement of the cardiac function of dilated cardiomyopathy mice.
    Tang Q; Shen D; Huang Z; Xiong R; Wu H; Huang J; Feng S; Niu P; Yang L; Bian Z
    Int J Cardiol; 2008 Jul; 127(3):442-3. PubMed ID: 18495274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different extent of cardiac malfunction and resistance to oxidative stress in heterozygous and homozygous manganese-dependent superoxide dismutase-mutant mice.
    Loch T; Vakhrusheva O; Piotrowska I; Ziolkowski W; Ebelt H; Braun T; Bober E
    Cardiovasc Res; 2009 Jun; 82(3):448-57. PubMed ID: 19293248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
    Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
    Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model.
    Foronjy RF; Sun J; Lemaitre V; D'Armiento JM
    Hypertens Res; 2008 Apr; 31(4):725-35. PubMed ID: 18633185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kidney androgen-regulated protein transgenic mice show hypertension and renal alterations mediated by oxidative stress.
    Tornavaca O; Pascual G; Barreiro ML; Grande MT; Carretero A; Riera M; Garcia-Arumi E; Bardaji B; González-Núñez M; Montero MA; López-Novoa JM; Meseguer A
    Circulation; 2009 Apr; 119(14):1908-17. PubMed ID: 19332469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice.
    Oberst L; Zhao G; Park JT; Brugada R; Michael LH; Entman ML; Roberts R; Marian AJ
    J Clin Invest; 1998 Oct; 102(8):1498-505. PubMed ID: 9788962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.